OptimizeRx Co. (NASDAQ:OPRX – Free Report) – Investment analysts at B. Riley issued their Q1 2025 earnings per share estimates for OptimizeRx in a research report issued on Wednesday, March 12th. B. Riley analyst A. Schock expects that the company will post earnings per share of ($0.34) for the quarter. B. Riley currently has a […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.